|
 |
|
|
 |
M.S.
(Pharmacokinetics), 2000.3-2002.2
Department of Pharmacy, Seoul National University,
Korea. |
|
B.S.
(Pharmacy), 1996.3-2000.2
Department of Pharmacy, Seoul National University,
Korea. |
|
2006.1 - present
Project Manager,
Asian Network for
Surveillance of Resistant
Pathogens
Asian-Pacific Research Foundation for Infectious
Disease (ARFID) |
|
2004. 8 - 2005. 5
ph D. candidate
Department of Pharmacy, University of Maryland,
Baltimore |
2003. 4 - 2005. 3
Pharmacist,
Drug Store |
|
2001. 12 - 2003. 3
Clinical Research Associate,
Department of Drug Development,
LG Life Sciences |
|
| Su
Yeon Yu, Soo Kyung Bae, Eun Jung Kim, Yoon
Gyoon Kim, Sun-Ok Kim, Dong Ha Lee, Hong Lim, and
Myung Gull Lee. Dose-independent pharmacokinetics
of a new reversible proton pump inhibitor, KR-60436,
after intravenous and oral administration to rats:
gastrointestinal first-pass effect. Journal of Pharmaceutical
Science 92 (8): 1592-16004, 2003 |
|
| Su
Yeon Yu, Hye Chin Chung, Eun Jung Kim,
So Hee Kim, Inchull Lee, Sang Geon Kim and Myung
Gull Lee. Effects of acute renal failure induced
by uranyl nitrate on the pharmacokinetics of intravenous
theophylline in rats: the role of CYP2E1 induction
in 1,3-dimethyluric acid formation. Journal of Pharmacy
and Pharmacology 54:1687-1692, 2002 |
|
Su
Yeon Yu, Eun Jung Kim, Sun-Ok Kim, Dong
Ha Lee, Hong Lim, Joong Kwon Choi and Myung Gull
Lee. HPLC analysis of a new reversible proton pump
inhibitor, a dihydropyrroloquinoline derivative,
in plasma, urine, and tissue homogenate. Journal
of Liquid Chromatography & Related Technologies
25 (17): 2687-2694, 2002
lisa@ansorp.org
|
|
|
|
|
|
|
